This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
by GTCR BC Holdings LLC, two major manufacturers of critical medical device coatings. Illinois Attorney General (AG) Kwame Raoul and Minnesota AG Keith Ellison have joined the Federal Trade Commission (FTC) in a lawsuit to block the acquisition of Surmodics Inc. By: Troutman Pepper Locke
SB 951 significantly limits the ability of management services organizations (“MSOs”) and professional medical entities to engage in the traditional structures of privateequity transactions. On June 9, 2025, Oregon enacted Senate Bill (“SB 951”). By: Benesch
When most people think of privateequity, manufacturing isn’t usually the first industry that comes to mind. According to PrivateEquity Info , over the past two years, there have been more than 1,060 manufacturing-focused privateequity transactions , a surprising figure that underscores the sector’s enduring appeal.
With ongoing demand for specialty drugs, biologics, and generics, privateequity sees long-term value in platforms that can scale and innovate within FDA-compliant environments. Medical Equipment and Supplies Manufacturing From surgical instruments to diagnostic devices, this sector is central to modern healthcare delivery.
*UPDATE* Oregon Senate Bill 951, described in the alert below originally published on May 30, 2025, was signed into law by Oregon Governor Tina Kotek on Monday, June 9, and will apply to all new investments beginning January 1, 2026, and all investments effective January 1, 2029. By: Goodwin
2025 Dental Transactions Update As of June 2025, our research shows approximately 130 privateequity backed DSOs operating across the dental services landscape – more than in any other healthcare vertical. DSO Creation Privateequity investment in dental practices began in the 1990’s when the first DSOs sought outside investors.
Privateequity investment in health care has grown significantly over the past two decades, and the US government is starting to pay attention. The False Claims Act (FCA) appears to be the first avenue of enforcement, but privateequity firms should be prepared for state. By: K&L Gates LLP
Compared to other medical fields like dentistry and dermatology, privateequity involvement in orthopedic practices has been relatively small. But that’s been changing over the past few years and is likely to continue to grow moving forward. Please see full Publication below for more information. By: FOCUS Investment Banking
Avista Capital Partners has announced it has acquired Terrats Medical from Miura Partners. Terrats, based in Barcelona, Spain, is a provider of dental prosthetics. The company sells into more than 50 countries. By: McGuireWoods LLP
M&M, founded in 1993 and based in South Plainfield, New Jersey, manufactures stainless steel tubing primarily for medical devices. Gainline Capital Partners has announced its acquisition of M&M International. By: McGuireWoods LLP
The complaint alleges that the transaction would violate antitrust laws by combining the #1 and #2 players in the provision of outsourced hydrophilic coatings for medical devices. (Surmodics). By: Goodwin
EBI, launched in 1979 and based in Parsippany, New Jersey, is a division of Highridge Medical that offers a portfolio of implantable and non-invasive bone growth stimulation solutions. Avista Healthcare Partners has announced the acquisition of EBI. By: McGuireWoods LLP
In the pursuit of attractive equity returns, privateequity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of privateequity-backed roll-up activity.
designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device markets and aerospace industries. New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 billion, according to industry reports. ILC, founded in 1947 and based in Frederica, Del., By: McGuireWoods LLP
This article focuses on how medical practices are valued by privateequity-backed groups, and to an extent, health systems and other strategic acquirers.
Privateequity funds have become major players in the professional health care delivery sector in recent years due to acquisitions of professional practices, including physician practices, senior living facilities and the like. Acquisitions of professional practices by privateequity funds involve myriad.
Marena , founded in 1994 and based in Lawrenceville, Georgia, is a manufacturer of medical-grade compression garments, specializing in post-surgical recovery solutions for invasive and non-invasive surgeries, mastectomy, maternity and post-pregnancy, and lipedema. Terms of the transaction were not disclosed.
When you hear the words “healthcare privateequity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?
Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—privateequity firms have a lot of capital to put to work. ENT and allergy is relatively new to privateequity investment, with approximately ten major platforms currently operating.
Compared to other medical fields like dentistry and dermatology, privateequity involvement in orthopedic practices has been relatively small. Despite the recent rash of M&A deals, the orthopedic business, like other medical fields, remains highly fragmented.
We are seeing an increasing amount of privateequity entering the veterinary space, both at the clinic level and the pet product level. Privateequity is already investing heavily in the pet industry, and it is expected to continue to grow. making it highly competitive to get into.
For top privateequity firms, there’s a lot to like about SaaS. Top Software PrivateEquity Firms Here is a select list of the most active PE investors in the SaaS and software industry over the past year (data taken from the SEG 2024 Annual SaaS Report ). The firm employs 93 professionals.
The 6th annual Midwest M&A/PrivateEquity Forum sponsored by the Thomson Reuters Institute was held in early December in Columbus, Ohio, and for your humble correspondent, this was not only my second time as one of the participants, but my first time as a moderator of a panel! More on that later.
This article focuses on how medical practices are valued by privateequity-backed groups, and to an extent, health systems and other strategic acquirers. Physician practices are almost always valued on a multiple of EBITDA basis in transactions with privateequity groups or similar buyers.
3 spot on The Deal’s privateequity league table for law firms. The combination with Waller gave Holland & Knight increased capabilities in healthcare, well as in privateequity, financial services, real estate and litigation. As of March, the merged entity had nearly 2,000 attorneys in 34 offices in the U.S.
Summary Privateequity-backed Physician Practice Management (“PPM”) companies in the ENT & Allergy space continued a conservative growth trajectory during Q1 2024. Introduction Privateequity groups began investing in the ear, nose, and throat and allergy space in 2018.
continues their goal of acquiring and integrating leading medical aesthetics clinics, enabling medical professionals in their subsidiaries to achieve personal and professional goals while creating world-class customer experiences by networking support, collaboration, and community.
Based on the large number of medical practices acquired over the past decade, you may think selling your practice is a routine process. Most physician practices have a rollover equity component, meaning that sellers receive an equity interest in the buyer organization as part of their transaction value.
Update on PrivateEquity and Insurance Brokerages In our ,, previous article , we reported that the COVID-19 pandemic had not diminished the pace of mergers and acquisitions transactions we are seeing in the insurance agency and brokerage sector. Privateequity firms continue to drive transaction pace and value.
On April 23 a group led by privateequity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 While the biggest recent deal, OneOncology is hardly the first oncology platform to be sold to a privateequity group. US Oncology Network.
PreK-12 Transactions PreK-12 Transaction Spotlight: Tyton Partners represented School Specialty in its Divestiture of EPS School Specialty , a PreK-12 supplemental curriculum provider, to Excolere Equity Partners. ISP Schools is a portfolio company of OMERS PrivateEquity.
For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.
The New York Times: Mergers, Acquisitions and Dive
JUNE 23, 2024
People have grown more attached to their pets — and more willing to spend money on them — turning animal medicine into a high-tech industry worth billions.
Targeting sectors with rigorous technical specifications, regulatory compliance standards, and exacting quality requirements, MSK serves customers primarily in the medical, aerospace & defense and telecommunications end markets.
Number of investments a year: Approx 10 Examples of previous investments: White Label Loyalty, Previsico, The Bunch, Beaconsoft and LightPoint Medical. Number of investments a year: 15 Examples of previous investments: Chargemaster, Ebury, Pod, PayasUgym, PowerX and Lightpoint Medical. Contact: john@advantagebusinessangels.co.uk
They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. “We Parallel ENT & Allergy is backed by Trinity Hunt Partners , a growth-oriented privateequity firm with deep healthcare experience. “We who serves as Michigan ENT’s managing partner.
Summary Privateequity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We also expect many platform recapitalizations once privateequity groups and lenders become comfortable with the interest rate environment. More groups are now looking to add oculoplastics and other sub-specialties.
They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. FOCUS Managing Directors Eric Yetter and Andy Snyder advised Dulles Eye Associates in this partnership.
They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. FOCUS managing directors Eric Yetter and Andy Snyder advised Mid-Michigan ENT in this partnership.
Serving a variety of end markets, including aerospace & defense, electronics and industrials, National offers especially deep experience in the medical end market across various implantable devices, including pacemakers, neuromodulation devices, defibrillators, batteries and capacitors. National”).
Healthcare-focused growth equity firm River Cities Capital Funds , or RC Capital , has linked up with James River Cardiology and formed Aligned Cardiovascular Partners. focuses on the healthcare services, medical device and healthcare IT sectors. The Provident team that advised James River was led by Eric Major and Ajeya Shekar.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content